department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ofatumumab · pharmadog

pharmadog
drugs
ofatumumab

drug

patient view →

ofatumumab

updated 2mo ago

by Henan Provincial People's Hospital

community read0 votes

all catalysts(1)

phase 1 2 completion · 1

phase 1 2 completion

Henan Provincial People's Hospital — ofatumumab (Phase I/II Trial Completion)

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3

drugKESIMPTA27 co-mentions · 14 sources
tagApproval26 co-mentions · 13 sources
companyHenan Provincial People's Hospital1 co-mentions · 1 sources

Trials studying ofatumumab

—Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumabenrolling by invitationn=75
—A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babiesactive not recruitingn=1,178
—Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in Franceactive not recruitingn=302
phase3Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumabactive not recruitingn=196
—Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Studycompletedn=107
—ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patientsactive not recruitingn=379
phase3An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumabcompletedn=562
—A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosisrecruitingn=700

more trials →